chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient scheduled an appointment for second COVID vaccine dose.  Clinic was administering Pfizer vaccine.  After receiving the Pfizer vaccine, patient presented her vaccination card, which showed the first dose she received was Moderna 044B21A on 4/22/21 in a different state.  No adverse events noted
On 05/19/2021 swollen cervical lymph node. That lasted for a couple of weeks and then I saw my PCP.   06/02/2021- I had blood work, an ultrasound was ordered, different tests. At the end of July I was diagnosed with  Hodgkin's Lymphoma.  I started chemotherapy at the beginning of September and I am currently still in treatment.
localized swelling extending to 13 cm. x 12 cm. --treated  initially with local ice, 1% hydrocortisone , and oral diphenhydramine--prescribed next day clindamycin for possible cellulitis
Full body rash began to appear approximately 1 hour after vaccination. Started on chest and spread over entire body. Was very itchy. Came and went and finally disappeared completely after 72 hours.  Also experienced dehydration and temporary decline in breastmilk production 24-48 hours after vaccinated.
Bumpy, red, mildly itchy rash on cheeks and forehead, lasted about 3 days. No other allergic symptoms
Pt recvd flu vax the next evening devel a rash & some blisters on breasts & back; dx w/herpes zoster; tx Zovirax & DPH; also exp inc BP & hallucinations; adm to hosp 12OCT92;
Diagnosed with SHINGLES one week after a receiving Covid booster shot.  Son also received booster at same location and lot number.  Also, diagnosed with SHINGLES one week after booster.  Son had SHINGLES vaccination in 2019 at a health care facility.  Two doses.
This spontaneous report was received from the Licensed Practical Nurse refers to, two unspecified patients of unknown demographics. On an unknown date, two patients were vaccinated with improperly stored ROTATEQ suspension, 2 ml, oral (strength, lot number was not reported) which was exposed to 76.1F for 32 minutes. No adverse effects were reported. No product quality complaint (PQC) involved. Additional information has been requested.
Extreme fatigue going on 2 1/2 weeks, feeling like I am going to pass out, burning sensations in head, tingling in head, hands and feet, numbness in feet, itchy skin, nausea, brain fog, heart palpitations
Red and puffy; Red spot; Sore arm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (Sore arm), VACCINATION SITE SWELLING (Red and puffy) and VACCINATION SITE ERYTHEMA (Red spot) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported). Concomitant products included PARACETAMOL (TYLENOL), OXYCODONE HYDROCHLORIDE (OXICODONE ACCORD), TRAMADOL and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 03-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Red and puffy) and VACCINATION SITE ERYTHEMA (Red spot). On 27-Jan-2021, VACCINATION SITE PAIN (Sore arm) had resolved. At the time of the report, VACCINATION SITE SWELLING (Red and puffy) and VACCINATION SITE ERYTHEMA (Red spot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Jaw pain started on 2/19/21. Over 24 hours, it progressed to numbness and paralysis of the right side of the face. Patient was diagnosed with Bells Palsy on the evening of 2/20/21. As of today's date, patient is still experiencing periodic right sided facial paralysis, jaw pain, taste disturbances, and distorted hearing.
Tingling in both legs.  No treatment, vitals stable.  Tingling resolved after a few minutes.  Also suffers from sciatica.
Woke up at 5:45 with a headache; intermittent fever; feeling very tired; This is a spontaneous report from a contactable Consumer or other non-HCP (Parent). A 20-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: EP6955) via an unspecified route of administration, administered on Right arm on 22Mar2021 at 12 pm as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. Medical history included Atopic Dermatitis. Patient had no known allergies. Concomitant medications were not reported. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 23Mar2021 at 05:45, the patient experienced "woke up at 5:45 with a headache" on 22Mar2021 at 12:00 am intermittent fever and feeling very tired. Patient did not receive any treatment for the events. Outcome of the event headache was recovered on 23Mar2021, outcome of other events was recovering.   Follow-up (24Mar2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported for a patient included Information about adverse events.   No follow-up attempts are possible. No further information is expected.
Patient became pale and stiffened after pt received VARIVAX and PPD. Placed on oxygen via face mask, albuterol neb x 1, Epinephrine 0.2 ml IM to lateral thigh administered. Pt was transferred to ED for further monitoring.
COVID 19 BREAKTHROUGH: 93 y/o female presents to the ED at a HCF with the CC of N/V/D x 1-2 months. Patient with PMH of Uterine/Cervical CA w/ mets to Peritoneum cavity and Malignant ascites last Chemo 4/4/22, Advance age, HLD, Dementia, HTN presented to the ED due to N/V/D x 1-2months. I called and spoke w/ daughter and husband. Pt lives w/ her daughter and husband. Daughter states that pt has not had a EGD or C scope in 15+ years. States that pt recently had a "clean CT abd 4/27" hence decided to stop Chemo; last Chemo was 4/4. BOOSTER 11-13-21
My daughter started to complain of chills, and later at home her temp was 102.8.  She had the flu vaccine at 4PM.
Tingling of mouth and soft palate. Congestion/tightening of nasal passages. Throat tightening.  Difficult to swallow. All within 1-2 min of vaccine. Felt scratchy throat from 5- 10 minutes. Loose stool with sudden onset 20min after vaccine. All symptoms improved to near baseline by 12noon. With only the Benadryl 50mg (premedication at 45min prior to vaccine)
Her arm barely hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm barely hurt) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN, CLONAZEPAM and ESTRADIOL for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Her arm barely hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Her arm barely hurt) outcome was unknown.            The action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-053183 (Patient Link).
PARENTS REPORTED THAT A FEW HOURS FOLLOWING MMRV AND D-TAP-IPV VACCINE, FEVER, NAUSEA, VOMITING, DIARRHEA, RASH TO PALMS/SOLES, REDNESS TO CHEST. REPORTED TO ED 1 MAR 2015, MOTRIN, ZOFRAN, AND BENADRYL GIVEN IN ED.
Strong Diarrhea after Second Shot; Stomach Pain after Second Shot; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Strong Diarrhea after Second Shot) and ABDOMINAL PAIN UPPER (Stomach Pain after Second Shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jun-2021, the patient experienced DIARRHOEA (Strong Diarrhea after Second Shot) and ABDOMINAL PAIN UPPER (Stomach Pain after Second Shot). At the time of the report, DIARRHOEA (Strong Diarrhea after Second Shot) and ABDOMINAL PAIN UPPER (Stomach Pain after Second Shot) outcome was unknown.            Concomitant product use was not provided.   Treatment information was not provided.
minutes after the vaccine patient states he felt light headed. Stated it had been a while since he had eaten. Given water and crackers. Took a sip and ate 2 crackers. Given ice pack for neck. O2Sat 99%, Pulse 70, RR 20, BP 145/104. State he is suppose to take medication for HTN but has not had them for a while. Continued to feel light headed. Placed in recovery position laying down. After laying him down he states his head was hurting. Talkative and alert. BP 160/120, Pulse 62. Respiratory Rate 16, O2sat 94%. At this time he stated he wanted to go to the hospital. EMS called and he was transported to Hospital.
right arm pain from her shoulder to where you arm bends in the elbow/ her other arm is killing her; She could not move her arm; This is a spontaneous report from a contactable consumer (patient). A 51-years-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm left on 19Sep2021 (at the age of 51 years old) as dose 1, single for COVID-19 immunization. Medical history included diabetes mellitus and thrombosis from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. On 20Sep2021, the patient experienced right arm pain from her shoulder to where you arm bends in the elbow/ her other arm is killing her, she could not move her arm. Patient reported that she once broke her left arm and went through physical therapy. She is using the physical therapy exercises she learned on her right arm, it continues to feel heavy and it hurts. Other clinical information includes Diagnosed before the Pfizer Covid19 vaccine; states she takes medication for this and takes Eliquis twice per day by mouth and does not have the dosage with her and started taking it for quite a while but can't remember; states she wants to say she has taken Eliquis for 6-8 months but was first on a medication that was stopped and she caught more blood clots and the first clot was in her leg, had one in her chest and the last one was in her groin 6 months ago and that is when she started Eliquis. The outcome of the event pain in arm was not recovered and rest event was unknown.   Follow-up attempts completed. No further information is expected.
Fever, up to 102.0;  joint pain, lasted about 24 hours.
Dizzy, disoriented, roaring in head, unable to stay awake, lowered blood pressure. Lasted approximately 15 hours. Extreme dry mouth.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 10:47 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 10:47 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 40.72.  Concomitant products were not provided.  On 15-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 6-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 9-May-2021.  On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 AM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42 and 5 PM: 42.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
presented to the ER on 4/5 with a CC of diarrhea  ongoing 5-6 days. found to be positive for c difficile.  was in the er on 4/3 with similar complaints and c diff testing was neg. he was recently at another hospital for an out pt visit for an egd and esophageal stretching for achalasia and received botox injections. he was found to have a uti and was treated with vantin which he completed on 3/26.  He got his covid vaccination on 3/29/2021. he was dc home on 4/7 on vancomycin po to complete a 14 day treatment course
Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old female patient who experienced redness at the injection site and screaming for 2 hours. The patient received a dose on an unspecified date. Additional suspect medication included ACT-HIB. The patient experienced redness at the injection site and screaming for 2 hours. The event resolved.
she fell; Pain in buttocks; This spontaneous case was reported by a consumer and describes the occurrence of FALL (she fell) and MUSCULOSKELETAL PAIN (Pain in buttocks) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FALL (she fell) and MUSCULOSKELETAL PAIN (Pain in buttocks). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, FALL (she fell) and MUSCULOSKELETAL PAIN (Pain in buttocks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.
Left arm from the site where injection given down to forearm red, swollen, requiring antibiotic Keflex treatment.
Nausea/vomiting. Lasted 3 days. Cramping of stomach with sharp pains. Diarrhea. Took PEPTO BISMOL & drank organic tea - no relief.
Pt received vaccine and on day of started to develop eczema lesions on extensor  in surface of elbows, hand and knees. Coincides & incidental switch of laundry detergent. Contact derm. vs. vaccine rxn unknown.
pt devel upper arm warmth & rash & assoc itching 6 days post vax;no pain, no gen rash;
extreme fatigue, headache, muscle pain, joint pain, nasal congestion, swollen glands, runny nose, 5 days  sneezing 2 days--all others EVERYDAY through today TX: Tylenol 3 days, Aleve 2, days continued
I started to notice a red sport on my left ankle that was 2 cm that was perfectly round. I went to my PCP and was prescribed a cream that did not work. I had a follow up with my PCP and was given a oral steroid which did not help. It started spreading all over my body. I went to a dermatologist and had 2 biopsies was diagnosed with Cutaneous T-cell lymphoma. I was referred to my oncologist then referred to a cancer clinic. I was recommended light therapy and a topical steroid. I had blood work and another biopsy that confirmed what my dermatologist had diagnosed me as. I am now going through chemotherapy.
After getting it I got COVID 19; After getting it I got COVID 19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "After getting it I got COVID 19". Additional information: The patient reported, "I was told I wouldn't get COVID after getting the vaccine. I got it. Both doses. Little less than a year after getting it I got COVID 19. I had it pretty bad. For longer than the usual time for it."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Event occurred after second injection in series approximately 36 days after the first. Red, raised bump approximately 2" in diameter developed at site of injection on right arm mid-deltoid within 36 hours. Site was hot to the touch with minor swelling down right arm and fingers. Patient reported that swelling and tenderness was increasing instead of decreasing. She did not take any antihistamines for reaction. I encouraged her to seek medical attention if swelling or pain continued to increase.
Optic Neuritis; Information has been received from a lawyer regarding a case in litigation concerning a female patient(pt) of unknown age.The pt's medical history, concurrent conditions and concomitant medications were not provided. On or around 18-SEP-2017, pt was inoculated with zoster vaccine live(ZOSTAVAX)for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live(ZOSTAVAX), pt suffered from Optic Neuritis. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt's symptoms have resulted in physical limitations not present prior to using zoster vaccine live(ZOSTAVAX). Pt also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of zoster vaccine live(ZOSTAVAX), pt sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live(ZOSTAVAX), pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.   Upon internal review, optic neuritis was determined to be medically significant. Optic neuritis was considered as disability by the reporter.
he is in the hospital with Encephalitis due to the Pfizer vaccine; dementia like symptoms; sudden loss of hearing; Can't walk; losing his voice; urinary incontinence; trouble swallowing; loss of personality flat affect; shaking of hands/full body tremor; weakness; fatigue; loss of interest; kind of in a "stupor state",; can't stay warm; trouble responding in conversations; confusion; falling asleep constantly; This is a spontaneous report from a contactable consumer reported for her father. An 80-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient had received both doses of the Pfizer Covid 19 vaccine. He was in the hospital with Encephalitis due to the Pfizer vaccine per his doctors. His symptoms were as follows: Can't walk, losing his voice, dementia like symptoms, urinary incontinence, trouble swallowing, loss of personality flat affect, shaking of hands, full body tremor, weakness, fatigue, loss of interest, kind of in a "stupor state", sudden loss of hearing, can't stay warm, trouble responding in conversations, confusion, falling asleep constantly. He had tons and tons of new symptoms and he had never had any of these problems. It had been reported to the CDC by the doctors. The outcome of the events was unknown.     No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Chills, aches, pain in joints, stabbing pains in my head along with the aching, some nausea, poor concentration, site was not clear
Sudden sharp pain in the right leg under the knee.  Making it difficult to walk and move.  Noticed three small bruises in the same area appeared around 1 hour after the pain started.  Also some swelling around the area.  And the area around the bruises is pale (white)  This happens today at 2:30 pm June 24  The vaccine was administered June 21 11:30 am
lump the size of a dime at the injection site at first; lump is warm to the touch; cellulitis; injection site area is itchy; A spontaneous case report was received from a health care professional, concerning herself who was 56 year-old female patient, who was administered Moderna's COVID-19 vaccine (mRNA-1273) and developed vaccination site mass, vaccination site pruritus, vaccination site warmth, and vaccination site cellulitis.   lump the size of a dime at the injection site at first, could see the injection site,injection site area is itchy,lump is the size of a mandarin ,lump is warm to the touch ,cellulitis .  The patient's medical history and concomitant medications were not provided. Concomitant medications included rivaroxaban, multivitamin, and vitamin B-complex.  0n 30-DEC-2020 , prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (batch number: 026L20A) intramuscularly in the left arm for the prophylaxis of COVID-19 infection.  On 06-JAN-2021, the injection site area was itchy. On 07-JAN-2021, at the injection site the lump was the size of a dime/mandarin, was warm to the touch, and was reportedly cellulitis. The patient was going to urgent care for treatment.  Action taken with mRNA-1273 in response to the events was not reported.   The  outcomes of the events, vaccination site mass, Vaccination site pruritus, vaccination site warmth, and vaccination site cellulitis, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.